Oriental-Tonic

Hydrolyzed milk protein for sleep, 7-OH ban in nutra regulatory round-up

South Korea’s MFDS is considering the approval of hydrolyzed milk protein as an ingredient for improving sleep quality. (Getty Images / Oppenheim Bernhard)

South Korea’s Ministry of Food and Drug Safety (MFDS) is considering the approval of hydrolyzed milk protein as an ingredient for improving sleep quality.

The MFDS is gathering public feedback on the above until September 22.

joint genesis

Currently, hydrolyzed milk protein can only be used in health functional foods on an individual approval basis and make the claim “may help relieve stress-related tension.”

Mitragyna speciosa (kratom) leaves with medicine products in powder, capsules and tablet in white ceramic bowl with wooden texture on background
Mitragyna speciosa (kratom) leaves with medicine products in powder, capsules and tablet in white ceramic bowl with wooden texture on background (Yanawut/Getty Images)

South Korea’s Ministry of Food and Drug Safety (MFDS) has reinforced an import ban on dietary supplements, jellies, and beverages containing 7-hydroxymitragynine (7-OH).

The regulator has also urged consumers to refrain from these products when doing cross-border e-commerce (CBEC) purchase.

The announcement came a week after the US FDA issued warning letters to companies for illegally marketing products containing concentrated 7-OH.

Nestlé is investing in the expansion of premium infant formula. Feeding bottle with infant formula and powder on violet  background.
Arla Foods Ingredients’ milk fat globule membrane (MFGM) has been approved for use as a nutritive substance in infant formula products in Australia. (Liudmila Chernetska/Image: Getty/Liudmila Chernetska)

The Food Standards Australia New Zealand (FSANZ) has approved the use of milk fat globule membrane (MFGM) as a nutritive substance in infant formula products in Australia for the first time.

Sourced from bovine milk, the MFGM approved is produced by Arla Foods Ingredients and is commercially available under the name “Lacprodan MFGM-10″.

The company will enjoy 15 months of exclusivity in supplying MFGM for use in infant formula products in Australia.

Elderly woman suffering from pain in knee. Tendon problems and Joint inflammation on dark background.
There are different types of joint health related claims that can be made in Japan, including those related to reducing pain / discomfort, increasing the range of motion, and improving actual physical ability. (ipopba/Getty Images)

Japan’s Foods with Function Claims (FFC) can now be formulated with methylsulfonylmethane (MSM) and make joint health claims.

MSM is widely used in dietary supplements brands in Japan.

However, this is the first time that MSM – specifically specialty ingredient manufacturer Balchem’s ingredient branded OptiMSM – has been allowed for use in FFC.

Vitamin-B6-rules-change-Australia-s-TGA-reviews-low-dose-intake-link-to-peripheral-neuropathy.jpg
The Therapeutic Goods Administration (TGA) is reviewing recent reported cases of vitamin B6 intake and the possible side effect of peripheral neuropathy. ©Getty Images (Bet_Noire/Getty Images/iStockphoto)

Over 100 vitamin B6 supplements could become “pharmacist-only” medicines in Australia by February 2027, the Therapeutic Goods Administration (TGA) announced.

The affected vitamin B6 supplements have a recommended daily dosage (RDD) of more than 50mg. A public consultation has been conducted on the issue and the final decision is pending.

As “pharmacist-only” medicines, these products would be regulated as Schedule 3 products and would only be available over the counter upon pharmacist advice.


Source link

JavaBurn ad banner

Written by : Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.

Share this article:

Leave A Comment